HBC — Hofseth Biocare ASA Share News
0.000.00%
Last trade - 00:00- NOK548.79m
- NOK778.72m
- NOK256.34m
Brief: Hofseth Biocare: Subsequent Offering Of Up To 8.9 Million New Shares
Brief: Hofseth Biocare announces net cash proceeds from private placement of NOK 57.4 mln
Brief: Hofseth Biocare Launches Private Placement, Consolidates Its Factories, Improves Production Process And Reduces Its Production Costs
Brief: Hofseth Biocare Q1 EBITDA Swings To Loss Of NOK 14.9 Million
Brief: Hofseth Biocare Q4 Operating Revenue Up At Nok 26.4 Million
Brief: Hofseth Biocare preliminary Total Revenues In Q4 at about NOK 26 mln
Brief: Hofseth Biocare Q3 EBITDA loss narrows to NOK 6.3 mln
Brief: Hofseth Biocare signs a NOK 35 mln financing agreement
Norway's Hofseth Biocare sees stronger results ahead as it enters commercial phase -CEO
Brief: Hofseth Biocare expects to report Q3 revenues of about NOK 28 mln
Brief: Hofseth Biocare: Roger Hofseth new CEO in HBC
Brief: Hofseth Biocare to sell and lease contracts of properties
Brief: Hofseth Biocare Q4 operating loss narrows to NOK 18.5 million
Brief: Hofseth Biocare Q3 EBITDA loss widens to NOK 41.2 mln
Brief: Hofseth Biocare reports final results of Subsequent Offering
Brief: Hofseth Biocare receives patent in the European Union
Brief: Hofseth Biocare Q2 operating loss widens to NOK 47.5 million
Brief: Hofseth biocare announces equity issue of minimum NOK 165 mln
Brief: Hofseth Biocare: OmeGo patent notice of allowance in US and new study on ProGo